|
๐
|
White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities
53 auth.
J. Alber,
S. Alladi,
H. Bae,
David A. Barton,
L. Beckett,
J. Bell,
S. Berman,
G. Biessels,
Sandra E. Black,
I. Bos,
G. Bowman,
E. Brai,
A. Brickman,
B. Callahan,
R. Corriveau,
...
S. Fossati,
R. Gottesman,
D. Gustafson,
V. Hachinski,
K. Hayden,
A. Helman,
T. Hughes,
J. Isaacs,
A. Jefferson,
Sterling C. Johnson,
A. Kapasi,
S. Kern,
Jay-Cheol Kwon,
J. Kukolja,
Athene Lee,
S. Lockhart,
A. Murray,
Katie E. Osborn,
M. Power,
Brittani R. Price,
Hanneke Rhodius-Meester,
Jacqueline A. Rondeau,
A. Rosen,
D. Rosene,
J. Schneider,
H. Scholtzova,
C. E. Shaaban,
N. C. Silva,
H. Snyder,
W. Swardfager,
A. Troen,
S. J. Veluw,
P. Vemuri,
A. Wallin,
C. Wellington,
D. Wilcock,
S. Xie,
A. Hainsworth
|
8 |
2019 |
8
๐
|
|
๐
|
The influence of diversity on the measurement of functional impairment: An international validation of the Amsterdam IADL Questionnaire in eight countries
21 auth.
M. Dubbelman,
Merike Verrijp,
D. Facal,
G. Sรกnchez-Benavides,
L. Brown,
W. M. van der Flier,
H. Jokinen,
Athene Lee,
I. Leroi,
C. Lojo-Seoane,
...
V. Miloลกeviฤ,
J. Molinuevo,
Arturo X. Pereiro Rozas,
C. Ritchie,
S. Salloway,
Gemma Stringer,
S. Zygouris,
B. Dubois,
S. Epelbaum,
P. Scheltens,
S. Sikkes
|
4 |
2019 |
4
๐
|
|
๐
|
Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease
42 auth.
Aylin Dincer,
B. Gordon,
Amrita Hari-Raj,
S. Keefe,
S. Flores,
Nicole S Mckay,
Angela M. Paulick,
Kristine E. Shady Lewis,
R. Feldman,
R. Hornbeck,
R. Allegri,
B. Ances,
S. Berman,
A. Brickman,
W. Brooks,
...
D. Cash,
J. Chhatwal,
M. Farlow,
Christian la Fougรจre,
Nick C Fox,
M. Fulham,
C. Jack,
N. Joseph-Mathurin,
C. Karch,
Athene Lee,
J. Levin,
C. Masters,
E. McDade,
Hwamee Oh,
R. Perrin,
Cyrus A. Raji,
S. Salloway,
P. Schofield,
Yi Su,
V. Villemagne,
Qing Wang,
M. Weiner,
C. Xiong,
I. Yakushev,
J. Morris,
R. Bateman,
Tammie L-S. Benzinger
|
4 |
2020 |
4
๐
|
|
๐
|
A Neuropsychological Perspective on Defining Cognitive Impairment in the Clinical Study of Alzheimer's Disease: Towards a More Continuous Approach.
13 auth.
R. Jutten,
L. Thompson,
S. Sikkes,
P. Maruff,
J. Molinuevo,
H. Zetterberg,
J. Alber,
D. Faust,
S. Gauthier,
M. Gold,
...
J. Harrison,
Athene Lee,
Peter J. Snyder
|
3 |
2022 |
3
๐
|
|
๐
|
Adding cognition to AT(N) models improves prediction of cognitive and functional decline
8 auth.
D. OโShea,
Kelsey R. Thomas,
Breton M. Asken,
Athene Lee,
Jennifer D. Davis,
P. Malloy,
...
S. Salloway,
S. Correia
|
3 |
2021 |
3
๐
|
|
๐
|
Using the Montreal cognitive assessment to identify individuals with subtle cognitive decline.
8 auth.
Tess E. K. Cersonsky,
Shanti Mechery,
Matthew M. Carper,
L. Thompson,
Athene Lee,
J. Alber,
...
I. Sarkar,
L. Brick
|
3 |
2022 |
3
๐
|
|
๐ข
|
Safety and Tolerability of APOE Genotyping and Disclosure in Cognitively Normal Volunteers From the Butler Alzheimerโs Prevention Registry
9 auth.
J. Alber,
D. Popescu,
L. Thompson,
G. Tonini,
Edmund Arthur,
Hwamee Oh,
...
S. Correia,
S. Salloway,
Athene Lee
|
2 |
2021 |
2
๐ข
|
|
๐ข
|
Frontal Behavior Syndromes in Idiopathic Normal Pressure Hydrocephalus as a Function of Alzheimerโs Disease Biomarker Status
7 auth.
M. Niermeyer,
C. Gaudet,
P. Malloy,
Irene Piryatinsky,
S. Salloway,
P. Klinge,
...
Athene Lee
|
2 |
2020 |
2
๐ข
|
